We report a case of Argentine hemorrhagic fever diagnosed in a woman in Belgium who traveled from a disease-endemic area. Patient management included supportive care and combination therapy with ribavirin and favipiravir. Of 137 potential contacts, including friends, relatives, and healthcare and laboratory workers, none showed development of clinical symptoms of this disease.
Keywords: Argentine hemorrhagic fever; Belgium; JUNV; Junin virus; New World arenaviruses; antiviral drugs; clinical management; containment; favipiravir; public health; ribavirin; travel; viruses.